ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Scientometrics |
Article Title |
Telomerase-related advances in hepatocellular carcinoma: A bibliometric and visual analysis
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Hai-Yang Li, Lin-Lin Zheng, Nan Hu, Zhi-Hao Wang, Chang-Cheng Tao, Ya-Ru Wang, Yue Liu, Zulihumaer Aizimuaji, Hong-Wei Wang, Rui-Qi Zheng, Ting Xiao and Wei-Qi Rong |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Beijing Hope Run Special Fund of Cancer Foundation of China |
LC2020L05 |
|
Corresponding Author |
Wei-Qi Rong, MD, Professor, Surgeon, Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan South Lane, Beijing 100021, China. dr_rongweiqi@163.com |
Key Words |
Telomerase; Bibliometric analysis; Telomerase reverse transcriptase; Prognosis; Treatment; Hepatocellular carcinoma |
Core Tip |
As a common event and promising biomarker in the early stage of hepatocellular carcinoma (HCC), telomerase activation is tightly connected to the survival rate and clinical prognosis of HCC patients. In this vein, the progress of immunotherapy and relevant studies on telomerase reverse transcriptase vaccination are strongly valuable. This study presents the first bibliometric analysis of telomerase-related research on HCC, offering a comprehensive overview of HCC-related telomerase studies. Keywords such as mutational landscape, telomerase reverse transcriptase promoter mutations, landscape, risk, and prognosis will be hot topics in the near future. |
Publish Date |
2024-03-06 06:10 |
Citation |
Li HY, Zheng LL, Hu N, Wang ZH, Tao CC, Wang YR, Liu Y, Aizimuaji Z, Wang HW, Zheng RQ, Xiao T, Rong WQ. Telomerase-related advances in hepatocellular carcinoma: A bibliometric and visual analysis. World J Gastroenterol 2024; 30(9): 1224-1236 |
URL |
https://www.wjgnet.com/1007-9327/full/v30/i9/1224.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v30.i9.1224 |